Clinical Trial Update: The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Metformin [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing whether adding ursodeoxycholic acid and probiotics to metformin improves metabolic outcomes in adults with Type 2 Diabetes Mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Probiotics
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University of Banja Luka | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED